These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 33848776)

  • 1. Research progress and application opportunities of nanoparticle-protein corona complexes.
    Huang W; Xiao G; Zhang Y; Min W
    Biomed Pharmacother; 2021 Jul; 139():111541. PubMed ID: 33848776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the Factors Influencing Chitosan-Based Nanoparticles-Protein Corona Interaction and Drug Delivery Applications.
    Moraru C; Mincea M; Menghiu G; Ostafe V
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33081296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
    Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
    Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro in-vivo correlation (IVIVC) in nanomedicine: Is protein corona the missing link?
    Jain P; Pawar RS; Pandey RS; Madan J; Pawar S; Lakshmi PK; Sudheesh MS
    Biotechnol Adv; 2017 Nov; 35(7):889-904. PubMed ID: 28844973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein corona, understanding the nanoparticle-protein interactions and future perspectives: A critical review.
    Kopac T
    Int J Biol Macromol; 2021 Feb; 169():290-301. PubMed ID: 33340622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How protein coronas determine the fate of engineered nanoparticles in biological environment.
    Capjak I; Goreta SŠ; Jurašin DD; Vrček IV
    Arh Hig Rada Toksikol; 2017 Dec; 68(4):245-253. PubMed ID: 29337683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protein corona and its effects on nanoparticle-based drug delivery systems.
    Li H; Wang Y; Tang Q; Yin D; Tang C; He E; Zou L; Peng Q
    Acta Biomater; 2021 Jul; 129():57-72. PubMed ID: 34048973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Crown and the Scepter: Roles of the Protein Corona in Nanomedicine.
    Cai R; Chen C
    Adv Mater; 2019 Nov; 31(45):e1805740. PubMed ID: 30589115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein corona: Dr. Jekyll and Mr. Hyde of nanomedicine.
    Fasoli E
    Biotechnol Appl Biochem; 2021 Dec; 68(6):1139-1152. PubMed ID: 33007792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy.
    Shang L; Nienhaus GU
    Acc Chem Res; 2017 Feb; 50(2):387-395. PubMed ID: 28145686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into colloidal nanoparticle-protein corona interactions for nanomedicine applications.
    Martínez-Negro M; González-Rubio G; Aicart E; Landfester K; Guerrero-Martínez A; Junquera E
    Adv Colloid Interface Sci; 2021 Mar; 289():102366. PubMed ID: 33540289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence correlation spectroscopy as a tool for the study of the intracellular dynamics and biological fate of protein corona.
    Martinez-Moro M; Di Silvio D; Moya SE
    Biophys Chem; 2019 Oct; 253():106218. PubMed ID: 31325709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction between nanoparticles-protein corona complex and cells and its toxic effect on cells.
    Liu N; Tang M; Ding J
    Chemosphere; 2020 Apr; 245():125624. PubMed ID: 31864050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The curious cases of nanoparticle induced amyloidosis during protein corona formation and anti-amyloidogenic nanomaterials: Paradox or prejudice?
    Randhawa S; Abidi SMS; Dar AI; Acharya A
    Int J Biol Macromol; 2021 Dec; 193(Pt A):1009-1020. PubMed ID: 34728302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of dynamic flow environment on nanoparticle-protein corona: From protein patterns to uptake in cancer cells.
    Palchetti S; Pozzi D; Capriotti AL; Barbera G; Chiozzi RZ; Digiacomo L; Peruzzi G; Caracciolo G; Laganà A
    Colloids Surf B Biointerfaces; 2017 May; 153():263-271. PubMed ID: 28273493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration-dependent protein adsorption at the nano-bio interfaces of polymeric nanoparticles and serum proteins.
    Zhang TX; Zhu GY; Lu BY; Zhang CL; Peng Q
    Nanomedicine (Lond); 2017 Nov; 12(22):2757-2769. PubMed ID: 29017387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein corona: a new approach for nanomedicine design.
    Nguyen VH; Lee BJ
    Int J Nanomedicine; 2017; 12():3137-3151. PubMed ID: 28458536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial engineering of the protein corona at bio-nano interfaces for improved cancer-targeted nanotherapy.
    Khan S; Sharifi M; Gleghorn JP; Babadaei MMN; Bloukh SH; Edis Z; Amin M; Bai Q; Ten Hagen TLM; Falahati M; Cho WC
    J Control Release; 2022 Aug; 348():127-147. PubMed ID: 35660636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering the protein corona: Strategies, effects, and future directions in nanoparticle therapeutics.
    Zhao T; Ren M; Shi J; Wang H; Bai J; Du W; Xiang B
    Biomed Pharmacother; 2024 Jun; 175():116627. PubMed ID: 38653112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bypassing Protein Corona Issue on Active Targeting: Zwitterionic Coatings Dictate Specific Interactions of Targeting Moieties and Cell Receptors.
    Safavi-Sohi R; Maghari S; Raoufi M; Jalali SA; Hajipour MJ; Ghassempour A; Mahmoudi M
    ACS Appl Mater Interfaces; 2016 Sep; 8(35):22808-18. PubMed ID: 27526263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.